216 related articles for article (PubMed ID: 38133879)
1. The Human GP130 Cytokine Receptor and Its Expression-an Atlas and Functional Taxonomy of Genetic Variants.
Chen YH; van Zon S; Adams A; Schmidt-Arras D; Laurence ADJ; Uhlig HH
J Clin Immunol; 2023 Dec; 44(1):30. PubMed ID: 38133879
[TBL] [Abstract][Full Text] [Related]
2. Functional and structural analysis of cytokine-selective IL6ST defects that cause recessive hyper-IgE syndrome.
Chen YH; Zastrow DB; Metcalfe RD; Gartner L; Krause F; Morton CJ; Marwaha S; Fresard L; Huang Y; Zhao C; McCormack C; Bick D; Worthey EA; Eng CM; Gold J; Undiagnosed Diseases Network ; Montgomery SB; Fisher PG; Ashley EA; Wheeler MT; Parker MW; Shanmugasundaram V; Putoczki TL; Schmidt-Arras D; Laurence A; Bernstein JA; Griffin MDW; Uhlig HH
J Allergy Clin Immunol; 2021 Aug; 148(2):585-598. PubMed ID: 33771552
[TBL] [Abstract][Full Text] [Related]
3. Mosaic IL6ST variant inducing constitutive GP130 cytokine receptor signaling as a cause of neonatal onset immunodeficiency with autoinflammation and dysmorphy.
Materna-Kiryluk A; Pollak A; Gawalski K; Szczawinska-Poplonyk A; Rydzynska Z; Sosnowska A; Cukrowska B; Gasperowicz P; Konopka E; Pietrucha B; Grzywa TM; Banaszak-Ziemska M; Niedziela M; Skalska-Sadowska J; Stawiński P; Śladowski D; Nowis D; Ploski R
Hum Mol Genet; 2021 Apr; 30(3-4):226-233. PubMed ID: 33517393
[TBL] [Abstract][Full Text] [Related]
4. New Dominant-Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130-Dependent Hyper-IgE Syndrome.
Arlabosse T; Materna M; Riccio O; Schnider C; Angelini F; Perreau M; Rochat I; Superti-Furga A; Campos-Xavier B; Héritier S; Pereira A; Deswarte C; Lévy R; Distefano M; Bustamante J; Roelens M; Borie R; Le Brun M; Crestani B; Casanova JL; Puel A; Hofer M; Fieschi C; Theodoropoulou K; Béziat V; Candotti F
J Clin Immunol; 2023 Oct; 43(7):1566-1580. PubMed ID: 37273120
[TBL] [Abstract][Full Text] [Related]
5. Absence of GP130 cytokine receptor signaling causes extended Stüve-Wiedemann syndrome.
Chen YH; Grigelioniene G; Newton PT; Gullander J; Elfving M; Hammarsjö A; Batkovskyte D; Alsaif HS; Kurdi WIY; Abdulwahab F; Shanmugasundaram V; Devey L; Bacrot S; Brodszki J; Huber C; Hamel B; Gisselsson D; Papadogiannakis N; Jedrycha K; Gürtl-Lackner B; Chagin AS; Nishimura G; Aschenbrenner D; Alkuraya FS; Laurence A; Cormier-Daire V; Uhlig HH
J Exp Med; 2020 Mar; 217(3):. PubMed ID: 31914175
[TBL] [Abstract][Full Text] [Related]
6. Selective loss of function variants in
Shahin T; Aschenbrenner D; Cagdas D; Bal SK; Conde CD; Garncarz W; Medgyesi D; Schwerd T; Karaatmaca B; Cetinkaya PG; Esenboga S; Twigg SRF; Cant A; Wilkie AOM; Tezcan I; Uhlig HH; Boztug K
Haematologica; 2019 Mar; 104(3):609-621. PubMed ID: 30309848
[TBL] [Abstract][Full Text] [Related]
7. Inborn errors of IL-6 family cytokine responses.
Chen YH; Spencer S; Laurence A; Thaventhiran JE; Uhlig HH
Curr Opin Immunol; 2021 Oct; 72():135-145. PubMed ID: 34044328
[TBL] [Abstract][Full Text] [Related]
8. A biallelic mutation in
Schwerd T; Twigg SRF; Aschenbrenner D; Manrique S; Miller KA; Taylor IB; Capitani M; McGowan SJ; Sweeney E; Weber A; Chen L; Bowness P; Riordan A; Cant A; Freeman AF; Milner JD; Holland SM; Frede N; Müller M; Schmidt-Arras D; Grimbacher B; Wall SA; Jones EY; Wilkie AOM; Uhlig HH
J Exp Med; 2017 Sep; 214(9):2547-2562. PubMed ID: 28747427
[TBL] [Abstract][Full Text] [Related]
9. Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting.
Zanders L; Kny M; Hahn A; Schmidt S; Wundersitz S; Todiras M; Lahmann I; Bandyopadhyay A; Wollersheim T; Kaderali L; Luft FC; Birchmeier C; Weber-Carstens S; Fielitz J
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):713-727. PubMed ID: 34821076
[TBL] [Abstract][Full Text] [Related]
10. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome.
Béziat V; Tavernier SJ; Chen YH; Ma CS; Materna M; Laurence A; Staal J; Aschenbrenner D; Roels L; Worley L; Claes K; Gartner L; Kohn LA; De Bruyne M; Schmitz-Abe K; Charbonnier LM; Keles S; Nammour J; Vladikine N; Maglorius Renkilaraj MRL; Seeleuthner Y; Migaud M; Rosain J; Jeljeli M; Boisson B; Van Braeckel E; Rosenfeld JA; Dai H; Burrage LC; Murdock DR; Lambrecht BN; Avettand-Fenoel V; Vogel TP; ; Esther CR; Haskologlu S; Dogu F; Ciznar P; Boutboul D; Ouachée-Chardin M; Amourette J; Lebras MN; Gauvain C; Tcherakian C; Ikinciogullari A; Beyaert R; Abel L; Milner JD; Grimbacher B; Couderc LJ; Butte MJ; Freeman AF; Catherinot É; Fieschi C; Chatila TA; Tangye SG; Uhlig HH; Haerynck F; Casanova JL; Puel A
J Exp Med; 2020 Jun; 217(6):. PubMed ID: 32207811
[TBL] [Abstract][Full Text] [Related]
11. Constitutively active mutant gp130 receptor protein from inflammatory hepatocellular adenoma is inhibited by an anti-gp130 antibody that specifically neutralizes interleukin 11 signaling.
Sommer J; Effenberger T; Volpi E; Waetzig GH; Bernhardt M; Suthaus J; Garbers C; Rose-John S; Floss DM; Scheller J
J Biol Chem; 2012 Apr; 287(17):13743-51. PubMed ID: 22523320
[TBL] [Abstract][Full Text] [Related]
12. A study of genes encoding cytokines (IL6, IL10, TNF), cytokine receptors (IL6R, IL6ST), and glucocorticoid receptor (NR3C1) and susceptibility to bronchopulmonary dysplasia.
Huusko JM; Karjalainen MK; Mahlman M; Haataja R; Kari MA; Andersson S; Toldi G; Tammela O; Rämet M; Lavoie PM; Hallman M;
BMC Med Genet; 2014 Nov; 15():120. PubMed ID: 25409741
[TBL] [Abstract][Full Text] [Related]
13. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours.
Rebouissou S; Amessou M; Couchy G; Poussin K; Imbeaud S; Pilati C; Izard T; Balabaud C; Bioulac-Sage P; Zucman-Rossi J
Nature; 2009 Jan; 457(7226):200-4. PubMed ID: 19020503
[TBL] [Abstract][Full Text] [Related]
14. Structural insights into IL-11-mediated signalling and human IL6ST variant-associated immunodeficiency.
Gardner S; Jin Y; Fyfe PK; Voisin TB; Bellón JS; Pohler E; Piehler J; Moraga I; Bubeck D
Nat Commun; 2024 Mar; 15(1):2071. PubMed ID: 38453915
[TBL] [Abstract][Full Text] [Related]
15. Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis.
Jenkins BJ; Roberts AW; Greenhill CJ; Najdovska M; Lundgren-May T; Robb L; Grail D; Ernst M
Blood; 2007 Mar; 109(6):2380-8. PubMed ID: 17082315
[TBL] [Abstract][Full Text] [Related]
16. Low incidence of IL6ST (gp130) mutations in exon 6 in lung cancer of a Chinese cohort.
Sun L; Sui L; Cong X; Ma K; Ma X; Huang Y; Fan C; Fu X; Ma K
Cancer Genet; 2014; 207(7-8):291-8. PubMed ID: 25242236
[TBL] [Abstract][Full Text] [Related]
17. A designer hyper interleukin 11 (H11) is a biologically active cytokine.
Dams-Kozlowska H; Gryska K; Kwiatkowska-Borowczyk E; Izycki D; Rose-John S; Mackiewicz A
BMC Biotechnol; 2012 Mar; 12():8. PubMed ID: 22433466
[TBL] [Abstract][Full Text] [Related]
18. Hyper-IgE syndrome, 2021 update.
Minegishi Y
Allergol Int; 2021 Oct; 70(4):407-414. PubMed ID: 34419355
[TBL] [Abstract][Full Text] [Related]
19. The amino acid exchange R28E in ciliary neurotrophic factor (CNTF) abrogates interleukin-6 receptor-dependent but retains CNTF receptor-dependent signaling via glycoprotein 130 (gp130)/leukemia inhibitory factor receptor (LIFR).
Wagener EM; Aurich M; Aparicio-Siegmund S; Floss DM; Garbers C; Breusing K; Rabe B; Schwanbeck R; Grötzinger J; Rose-John S; Scheller J
J Biol Chem; 2014 Jun; 289(26):18442-50. PubMed ID: 24802752
[TBL] [Abstract][Full Text] [Related]
20. Inherited human ZNF341 deficiency.
Béziat V; Fieschi C; Momenilandi M; Migaud M; Belaid B; Djidjik R; Puel A
Curr Opin Immunol; 2023 Jun; 82():102326. PubMed ID: 37080116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
